What is Nexgen Compounding Pharmacy?
NexGen Pharmaceuticals specializes in veterinary compounding, offering a comprehensive portfolio of pharmaceuticals for companion, equine, non-domestic, and exotic animals. Their offerings encompass both branded and generic medications, with a particular emphasis on sourcing hard-to-find drugs and developing custom formulations tailored to the unique requirements of veterinary medicine. The company is dedicated to maintaining high standards of compound quality and delivering exceptional customer service, collaborating closely with veterinarians to address a wide spectrum of animal health challenges. NexGen's pharmacists are integral to the dispensing process and provide expert guidance, aiming for optimal therapeutic outcomes across a diverse animal patient base.
How much funding has Nexgen Compounding Pharmacy raised?
Nexgen Compounding Pharmacy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nexgen Compounding Pharmacy
PPP
Public-Private Partnership
What's next for Nexgen Compounding Pharmacy?
The recent major strategic investment signals a pivotal growth phase for Nexgen Compounding Pharmacy. This capital infusion is likely to fuel strategic initiatives such as expanding its formulation capabilities, enhancing its supply chain for rare medications, and potentially broadening its market reach within the veterinary sector. The company's focus on custom solutions and hard-to-find drugs positions it favorably to capitalize on increasing demand for specialized animal healthcare. Future developments may include technological advancements in compounding processes and strategic partnerships to further solidify its market leadership.
See full Nexgen Compounding Pharmacy company page
